Justice Department Announces Medical Marijuana Schedule III Listing
The medical marijuana Schedule III reclassification marks a pivotal shift in federal cannabis policy. This change removes major barriers to research, enabling new clinical trials. Medical marijuana Schedule III reclassification opens pathways for…
Is The DEA Still Stuck In The Reefer Madness Era? About Weed! | Cbd Oil Lotion Whole Foods
DEA cannabis policy updates continue to influence patient access to cannabis medicine and research opportunities. Understanding these changes is crucial for clinicians navigating current legal frameworks. This article highlights the ongoing challenges…
Policy Watch: 10 Regulatory Updates — April 01, 2026
Policy WatchApril 01, 2026. 10 regulatory items above the clinical relevance threshold of 40. Sources include Federal Register, regulations.gov, and regulatory RSS feeds. Listed in descending order of relevance score. Score 70Federal RegisterSchedules of…
CED Regulatory Digest, Since Last Digest, 1 items
Digest covering 1 recent regulatory items.
America Doesn’t Have a Marijuana Problem, It Has a Cannabis Education Gap
The cannabis education gap is a critical issue slowing clinical program development and physician training. Without proper cannabis education, patients lack access to safe, guided care. Addressing this gap is essential for advancing clinical cannabis use.